Skip to main content
Clinical Trials/NCT01141764
NCT01141764TerminatedPhase 3

Cerebral Metabolic Changes Associated With Thalamic Stimulation

The Hospital for Sick Children4 sites in 1 country4 target enrollmentStarted: March 2010Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Terminated
Enrollment
4
Locations
4
Primary Endpoint
Areas of the brain with low activity

Study Overview

Brief Summary

The purpose of this research study is to evaluate the brain circuits function and circuits involved in the mechanism of thalamic DBS in patients with medically refractory epilepsy.

Detailed Description

Deep brain stimulation (DBS) of the anterior nucleus of the thalamus in patients with medically refractory epilepsy has been shown to be efficacious. Studies have estimated a 46-76% reduction in seizures relative to the baseline. However, the exact anatomic circuitry involved in the mechanism of DBS in epilepsy remains unknown. Positron emission tomography (PET) studies can provide clues to the metabolic activity associated with DBS activation. In our study, patients will be scanned with their DBS electrodes turned "on" and "off". PET data captured during these two distinct states may show characteristic differences in cerebral glucose metabolism and modulatory effects of surrounding cerebral structures, thus providing clues to how DBS works to prevent seizures.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18-85 years old
  • currently have DBS implanted for medically refractory epilepsy
  • Women of childbearing age will be required to use established contraceptive methods while enrolled in the study.

Exclusion Criteria

  • Patients who:
  • are < 18 years of age or > 85 years of age
  • are medically unstable
  • are women who are potentially pregnant, pregnant or nursing
  • have had PET imaging within 1 year.

Outcomes

Primary Outcomes

Areas of the brain with low activity

Time Frame: within 30 days of enrollment in the study

This measure will be based on the results of two PET scans done on separate days. The stimulator will be "on" during the first PET image acquisition and "off" during the second PET image acquisition.

Secondary Outcomes

  • Brain Abnormalities(within 30 days of enrollment in the study)
  • Ability to learn and understand(within 30 days of enrollment in the study)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Elysa Widjaja

Staff Neuroradiologist

The Hospital for Sick Children

Study Sites (4)

Loading locations...

Similar Trials

Cerebral Metabolic Changes Associated With... | Clinical Trial